Conrad Wai
CEO, Counterpart Health · CLOVER HEALTH INVESTMENTS, CORP. /DE
- 2024
- Sep 16, 2026
- 17
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Conrad Wai files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Toy - $3.70M in CLOV purchases and sales in the last 12 months
- Brady Patrick Priest - $725K in CLOV purchases and sales in the last 12 months
- Jamie L. Reynoso - $481K in CLOV purchases and sales in the last 12 months
- Karen Soares - $337K in CLOV purchases and sales in the last 12 months
- Carladenise Armbrister Edwards - $230K in CLOV purchases and sales in the last 12 months
- Joseph Frank Oldakowski - $177K in CLOV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Conrad Wai?
Conrad Wai is a corporate insider, tracked as CEO, Counterpart Health of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Conrad Wai submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Conrad Wai been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($3.15M) across all tracked filings.